aranidipine has been researched along with Blood Pressure, High in 11 studies
aranidipine: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effect of aranidipine enteric-coated capsules on 24 h blood pressure and blood pressure variability (BPV) in patients with mild to moderate essential hypertension." | 9.17 | [The effects of aranidipine on ambulatory blood pressures in patients with mild to moderate essential hypertension]. ( Chen, L; Hua, Q; Jiang, H; Jiao, Y; Jin, H; Ke, YN; Sun, RH; Wang, Y; Yang, HY; Zheng, JT, 2013) |
| "To assess the efficacy and safety of aranidipine versus retard-released felodipine in Chinese patients with mild-to-moderate essential hypertension." | 9.17 | [Efficacy and safety of aranidipine in Chinese patients with mild-to-moderate essential hypertension]. ( Chen, L; Jiao, Y; Jin, H; Ke, YN; Li, DY; Liu, MX; Wang, BY; Wang, L; Wang, Y; Yang, HY; Zhao, XL; Zheng, JT, 2013) |
| " Adverse events occurred at 11." | 6.77 | Efficacy and safety of aranidipine enteric-coated tablets compared with amlodipine in Chinese patients with mild to moderate essential hypertension: a multicenter, randomized, double-blind, parallel-controlled clinical trial. ( Chen, GL; Fan, CM; Li, HM; Li, YS; Lin, YZ; Pang, HM; Wang, L; Wu, SY; Yan, LR; Yu, J; Zhao, RP, 2012) |
| "To evaluate the effect of aranidipine enteric-coated capsules on 24 h blood pressure and blood pressure variability (BPV) in patients with mild to moderate essential hypertension." | 5.17 | [The effects of aranidipine on ambulatory blood pressures in patients with mild to moderate essential hypertension]. ( Chen, L; Hua, Q; Jiang, H; Jiao, Y; Jin, H; Ke, YN; Sun, RH; Wang, Y; Yang, HY; Zheng, JT, 2013) |
| "To assess the efficacy and safety of aranidipine versus retard-released felodipine in Chinese patients with mild-to-moderate essential hypertension." | 5.17 | [Efficacy and safety of aranidipine in Chinese patients with mild-to-moderate essential hypertension]. ( Chen, L; Jiao, Y; Jin, H; Ke, YN; Li, DY; Liu, MX; Wang, BY; Wang, L; Wang, Y; Yang, HY; Zhao, XL; Zheng, JT, 2013) |
| "The effects of MPC-1304, a new calcium channel blocker, on blood pressure, serum lipoproteins, and carbohydrate metabolism were compared with those of atenolol in a group of patients with mild to moderate essential hypertension." | 5.08 | Effects of a new calcium channel blocker, MPC-1304, on blood pressure, serum lipoproteins and serum carbohydrate metabolism in patients with essential hypertension. ( Arakawa, K; Kajiyama, G; Kusukawa, R; Mashiba, H; Nonaka, K; Sasaki, J; Shichiri, M; Sunaga, T; Tanaka, N, 1995) |
| " Adverse events occurred at 11." | 2.77 | Efficacy and safety of aranidipine enteric-coated tablets compared with amlodipine in Chinese patients with mild to moderate essential hypertension: a multicenter, randomized, double-blind, parallel-controlled clinical trial. ( Chen, GL; Fan, CM; Li, HM; Li, YS; Lin, YZ; Pang, HM; Wang, L; Wu, SY; Yan, LR; Yu, J; Zhao, RP, 2012) |
| "3-3 mg/kg), dose-response curves of the antihypertensive effect did not change and body weight gain was equal to that of the vehicle-treated group." | 1.28 | Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs. ( Haruno, A; Kanda, A; Miyake, H; Nagasaka, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L | 2 |
| Jiang, H | 1 |
| Hua, Q | 1 |
| Yang, HY | 2 |
| Zheng, JT | 2 |
| Jin, H | 2 |
| Jiao, Y | 2 |
| Wang, Y | 2 |
| Sun, RH | 1 |
| Ke, YN | 2 |
| Zhao, XL | 1 |
| Liu, MX | 1 |
| Wang, L | 2 |
| Wang, BY | 1 |
| Li, DY | 1 |
| Yan, LR | 1 |
| Li, YS | 1 |
| Chen, GL | 1 |
| Pang, HM | 1 |
| Wu, SY | 1 |
| Yu, J | 1 |
| Li, HM | 1 |
| Lin, YZ | 1 |
| Zhao, RP | 1 |
| Fan, CM | 1 |
| Hasegawa, K | 1 |
| Wakino, S | 1 |
| Kanda, T | 1 |
| Yoshioka, K | 1 |
| Tatematsu, S | 1 |
| Homma, K | 1 |
| Takamatsu, I | 1 |
| Sugano, N | 1 |
| Hayashi, K | 1 |
| Sasaki, J | 1 |
| Kajiyama, G | 1 |
| Kusukawa, R | 1 |
| Shichiri, M | 1 |
| Sunaga, T | 1 |
| Mashiba, H | 1 |
| Tanaka, N | 1 |
| Nonaka, K | 1 |
| Arakawa, K | 1 |
| Suzuki, S | 1 |
| Hashimoto, T | 1 |
| Kusano, S | 1 |
| Kapuku, K | 1 |
| Utsunomiya, T | 1 |
| Yano, K | 1 |
| Okumura, K | 2 |
| Ichihara, K | 2 |
| Nagasaka, M | 3 |
| Oda, N | 1 |
| Tajima, K | 1 |
| Miyoshi, K | 2 |
| Kanda, A | 3 |
| Nozawa, Y | 2 |
| Nakano, M | 1 |
| Miyake, H | 4 |
| Yamada, S | 1 |
| Uchida, S | 1 |
| Ohkura, T | 1 |
| Kimura, R | 1 |
| Kamei, H | 1 |
| Kanno, T | 1 |
| Haruno, A | 1 |
4 trials available for aranidipine and Blood Pressure, High
| Article | Year |
|---|---|
[The effects of aranidipine on ambulatory blood pressures in patients with mild to moderate essential hypertension].
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulat | 2013 |
[Efficacy and safety of aranidipine in Chinese patients with mild-to-moderate essential hypertension].
Topics: Antihypertensive Agents; Dihydropyridines; Double-Blind Method; Essential Hypertension; Felodipine; | 2013 |
Efficacy and safety of aranidipine enteric-coated tablets compared with amlodipine in Chinese patients with mild to moderate essential hypertension: a multicenter, randomized, double-blind, parallel-controlled clinical trial.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; D | 2012 |
Effects of a new calcium channel blocker, MPC-1304, on blood pressure, serum lipoproteins and serum carbohydrate metabolism in patients with essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Apolipoprotein A-II; Apolipoproteins; Atenolol; Blood Glucose; | 1995 |
7 other studies available for aranidipine and Blood Pressure, High
| Article | Year |
|---|---|
Divergent action of calcium channel blockers on ATP-binding cassette protein expression.
Topics: Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Calcium Chan | 2005 |
Effect of a new calcium antagonist on hemodynamics at rest and exercise loading in patients with essential hypertension.
Topics: Aged; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Exercise; Female; Hemodynamics; Hu | 1993 |
Calcium entry blocking activities of MPC-1304 and of its enantiomers and metabolites.
Topics: Animals; Blood Pressure; Calcium; Calcium Channel Blockers; Dihydropyridines; Hypertension; In Vitro | 1993 |
Regional vascular effects of MPC-1304, a novel dihydropyridine derivative, in conscious normotensive and spontaneously hypertensive rats.
Topics: Animals; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Heart Rate | 1996 |
Receptor occupation and pharmacokinetics of MPC-1304, a new Ca2+ channel antagonist, in spontaneously hypertensive rats.
Topics: Administration, Oral; Animals; Aorta; Binding, Competitive; Calcium Channel Blockers; Cerebral Corte | 1995 |
Renal effects of the calcium channel blocker aranidipine and its active metabolite in anesthetized dogs and conscious spontaneously hypertensive rats.
Topics: Administration, Oral; Animals; Blood Pressure; Calcium Channel Blockers; Creatinine; Dihydropyridine | 1998 |
Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Co | 1992 |